KLRN SciTech Now
Jan. 27, 2017 | Revolutionizing the delivery of medicine
Season 2 Episode 3 | 26m 46sVideo has Closed Captions
Study describes a capsule that can deliver medicinal doses over several days or a few week
A new study by Lyle Hood, assistant professor of mechanical engineering at The University of Texas at San Antonio, describes a new device that could revolutionize the delivery of medicine to treat cancer as well as other diseases and ailments. The capsule can deliver medicinal doses over several days or a few weeks. It can be used for any ailment that needs a localized delivery.
Problems playing video? | Closed Captioning Feedback
Problems playing video? | Closed Captioning Feedback
KLRN SciTech Now is a local public television program presented by KLRN
Support provided by viewers like you and the 80/20 Foundation.
KLRN SciTech Now
Jan. 27, 2017 | Revolutionizing the delivery of medicine
Season 2 Episode 3 | 26m 46sVideo has Closed Captions
A new study by Lyle Hood, assistant professor of mechanical engineering at The University of Texas at San Antonio, describes a new device that could revolutionize the delivery of medicine to treat cancer as well as other diseases and ailments. The capsule can deliver medicinal doses over several days or a few weeks. It can be used for any ailment that needs a localized delivery.
Problems playing video? | Closed Captioning Feedback
How to Watch KLRN SciTech Now
KLRN SciTech Now is available to stream on pbs.org and the free PBS App, available on iPhone, Apple TV, Android TV, Android smartphones, Amazon Fire TV, Amazon Fire Tablet, Roku, Samsung Smart TV, and Vizio.
Providing Support for PBS.org
Learn Moreabout PBS online sponsorship
- Science and Nature
Explore scientific discoveries on television's most acclaimed science documentary series.
- Science and Nature
Capturing the splendor of the natural world, from the African plains to the Antarctic ice.
Support for PBS provided by:
KLRN SciTech Now is a local public television program presented by KLRN
Support provided by viewers like you and the 80/20 Foundation.